Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Insulet Corporation | PODD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 167.25 | 05:19:13 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 167.25 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 125.82 - 335.91 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 167.25 | USD |
Insulet (PODD) Options Flow Summary
Insulet Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.7B | 69.93M | - | 1.7B | 206.3M | 2.95 | 56.69 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Insulet News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PODD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 166.44 | 169.34 | 162.11 | 165.98 | 665,052 | 0.81 | 0.49% |
| 1 Month | 170.00 | 180.01 | 161.68 | 169.94 | 701,485 | -2.75 | -1.62% |
| 3 Months | 193.00 | 202.72 | 160.84 | 175.19 | 857,292 | -25.75 | -13.34% |
| 6 Months | 139.50 | 223.56 | 128.68 | 179.57 | 974,299 | 27.75 | 19.89% |
| 1 Year | 318.84 | 335.91 | 125.82 | 196.57 | 969,038 | -151.59 | -47.54% |
| 3 Years | 295.94 | 335.91 | 125.82 | 233.55 | 670,323 | -128.69 | -43.49% |
| 5 Years | 83.44 | 335.91 | 82.185 | 216.24 | 631,106 | 83.81 | 100.44% |
Insulet Description
| Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide. |
